Skip to main content

Human Pluripotent Stem Cell-Based Assays to Predict Developmental Toxicity

  • Protocol
  • First Online:
Teratogenicity Testing

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2753))

  • 236 Accesses

Abstract

Human beings are continuously exposed to various toxic substances throughout their lives, which affect their reproductive health and eventually the offspring they give birth to. Mainly, these toxins damage the heart and neurological development of the newborn, but most recently, they have begun to affect the musculoskeletal system as well. These toxins are usually present in food, pharmaceuticals, cosmetics, or even the polluted air that people breathe; as a result, the prevalence of birth defects is steadily rising. For this reason, it becomes a necessity to deploy a new set of assays to test for such toxins in industries to decrease the occurrence of developmental toxicity. These assays are exceedingly expensive when carried out conventionally using animal models or cells from such sources and have a lower predictive value due to the vast variation between animals and humans. To overcome such major problems, human pluripotent stem cells are now frequently used for these assays. These cells are easily available, are quickly generated from somatic cells (induce pluripotent stem cells), can be of human origin without harming people, and eliminate animal harm, which makes them the top choice of scientists for carrying out any in vitro developmental toxicity assays.

This chapter, therefore, provides an overview of several steps that can be used to predict a compound’s developmental toxicity by utilizing human pluripotent stem cells. Here, the easiest and most effective procedure has been outlined that can screen many compounds simultaneously.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kanno S, Okubo Y, Kageyama T, Yan L, Kitajima S, Fukuda J (2022) Establishment of a developmental toxicity assay based on human iPSC reporter to detect FGF signal disruption. iScience 25(2):103770. https://doi.org/10.1016/j.isci.2022.103770

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Gupta PK (2020) Problem solving questions in toxicology. https://doi.org/10.1007/978-3-030-50409-0

    Book  Google Scholar 

  3. Jamkhande PG, Chintawar KD, Chandak PG (2014) Teratogenicity: a mechanism based short review on common teratogenic agents. Asian Pac J Trop Dis 4(6):421–432. https://doi.org/10.1016/S2222-1808(14)60600-9

    Article  CAS  Google Scholar 

  4. van Gelder MMHJ, van Rooij IALM, Miller RK, Zielhuis GA, de Jong-van den Berg LTW, Roeleveld N (2010) Teratogenic mechanisms of medical drugs. Hum Reprod Update 16(4):378–394. https://doi.org/10.1093/humupd/dmp052

    Article  PubMed  CAS  Google Scholar 

  5. Martin PL, Weinbauer GF (2010) Invited reviews: developmental toxicity testing of biopharmaceuticals in nonhuman primates: previous experience and future directions. Int J Toxicol 29(6):552–568. https://doi.org/10.1177/1091581810378896

    Article  PubMed  CAS  Google Scholar 

  6. Hansen DK, Inselman AL (2011) Applications of stem cells in developmental toxicology. Elsevier Inc. https://doi.org/10.1016/B978-0-12-382032-7.10058-X

    Book  Google Scholar 

  7. Lee S, Bochanis A, Rasmussen TP (2019) Pluripotent cells for the assessment of chemically induced teratogenesis and developmental toxicology. Elsevier Inc. https://doi.org/10.1016/B978-0-12-816221-7.00007-0

    Book  Google Scholar 

  8. Li S, Yang R, Yin N, Zhao M, Zhang S, Faiola F (2023) Developmental toxicity assessments for TBBPA and its commonly used analogs with a human embryonic stem cell liver differentiation model. Chemosphere 310:136924. https://doi.org/10.1016/j.chemosphere.2022.136924

    Article  PubMed  CAS  Google Scholar 

  9. Madrid JV, Sera SR, Sparks NRL, Zur Nieden NI (2018) Human pluripotent stem cells to assess developmental toxicity in the osteogenic lineage. Methods Mol Biol 1797:125–145

    Google Scholar 

  10. Lian X et al (2013) Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat Protoc 8(1):162–175. https://doi.org/10.1038/nprot.2012.150

    Article  PubMed  CAS  Google Scholar 

  11. Schwartz MP et al (2015) Human pluripotent stem cell-derived neural constructs for predicting neural toxicity. Proc Natl Acad Sci U S A 112(40):12516–12521. https://doi.org/10.1073/pnas.1516645112

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Shinde V et al (2015) Human pluripotent stem cell based developmental toxicity assays for chemical safety screening and systems biology data generation. J Vis Exp 100:2015. https://doi.org/10.3791/52333

    Article  CAS  Google Scholar 

  13. Kobolak J et al (2020) Human induced pluripotent stem cell-derived 3D-neurospheres are suitable for neurotoxicity screening. Cell 9(5). https://doi.org/10.3390/cells9051122

  14. Mantziou V, Baillie-Benson P, Jaklin M, Kustermann S, Arias AM, Moris N (2021) In vitro teratogenicity testing using a 3D, embryo-like gastruloid system. Reprod Toxicol 105:72–90. https://doi.org/10.1016/j.reprotox.2021.08.003

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Moris N et al (2020) Generating human gastruloids from human embryonic stem cells. Res Sq Protoc Exch:1–16, [Online]. Available: https://protocolexchange.researchsquare.com/article/pex-812/latest?utm_source=researcher_app&utm_medium=referral&utm_campaign=RESR_MRKT_Researcher_inbound

  16. Jaklin M et al (2022) Optimization of the TeraTox assay for preclinical teratogenicity assessment. Toxicol Sci 188(1):17–33. https://doi.org/10.1093/toxsci/kfac046

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Gamble JT, Hopperstad K, Deisenroth C (2022) The DevTox germ layer reporter platform: an assay adaptation of the human pluripotent stem cell test. Toxics 10(7):1–24. https://doi.org/10.3390/toxics10070392

    Article  CAS  Google Scholar 

  18. Witt G et al (2021) An automated and high-throughput-screening compatible pluripotent stem cell-based test platform for developmental and reproductive toxicity assessment of small molecule compounds. Cell Biol Toxicol 37(2):229–243. https://doi.org/10.1007/s10565-020-09538-0

    Article  PubMed  CAS  Google Scholar 

  19. Lauschke K et al (2020) A novel human pluripotent stem cell-based assay to predict developmental toxicity. Arch Toxicol 94(11):3831–3846. https://doi.org/10.1007/s00204-020-02856-6

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Acknowledgments

The authors want to acknowledge and express gratitude toward our guide Dr. Satarupa Banerjee (SBST, VIT Vellore) and our fellow PhD scholars for constantly guiding us and the staff and management of VIT Vellore for providing us the opportunity to carry our study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satarupa Banerjee .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Banerjee, M., Das, A., Chatterjee, P., Banerjee, S. (2024). Human Pluripotent Stem Cell-Based Assays to Predict Developmental Toxicity. In: FĂ©lix, L. (eds) Teratogenicity Testing. Methods in Molecular Biology, vol 2753. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3625-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-3625-1_8

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-3624-4

  • Online ISBN: 978-1-0716-3625-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics